RubyAnneDeverasMD

Oncology • Daytona Beach, FL

Physician

Join to view full profile

Dr. Deveras is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Deveras' full profile

Already have an account?

Office
303 N Clyde Morris Blvd
Halifax Regional Oncology Center
Daytona Beach, FL 32114
Phone+1 386-254-4212

Fax+1 386-254-4214

Education & Training

Georgetown University HospitalFellowship, Medical Oncology, 1999 - 2002
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1996 - 1999
Stony Brook University Health Sciences Center School of MedicineClass of 1996

Certifications & Licensure

FL State Medical License 1998 - 2027
DC State Medical License 1999 - 2008
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013

Clinical Trials

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
ACTIVE_NOT_RECRUITING
PHASE3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Start of enrollment: 2011 May 16
Completed
Not Applicable
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
ACTIVE_NOT_RECRUITING
PHASE3
NBRST: Prospective Neo-adjuvant REGISTRY Trial Start of enrollment: 2011 Jul 01
Completed
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score Start of enrollment: 2012 May 01
Completed
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer Start of enrollment: 2014 Oct 03
ACTIVE_NOT_RECRUITING
PHASE3
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Start of enrollment: 2015 Jul 26
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

2 citations
Germline VHL Mutation Discovered in Association with EGFR-Positive Lung Cancer and Metachronous Hepatocellular Carcinoma: A Case Report.
Justin J Kuhlman, Quinn J Frier, Daniel Sumarriva, Matthew J. Oberley, Danielle Bolton
Case Reports in Oncology. 2021-09-16
2 citations
The impact of the affordable care act on breast cancer care in the USA: A multi-institutional analysis.
Jessica A. Maxwell, Oleg Shats, Joshua Aldridge, Elizabeth Lyden, Amy Krie
The Breast Journal. 2019-09-01
5 citations
Potential risks of chronic sildenafil use for priapism in sickle cell disease.
Andrew Lane, Ruby Deveras
The Journal of Sexual Medicine. 2011-11-01

Professional Memberships

American Society of Clinical Oncology - ASCO
Member